These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 36291754)
1. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy. Zheng Y; Gao Q; Su X; Xiao C; Yu B; Huang S; Sun Y; Wu S; Wo Y; Xu Q; Xu N; Yu H Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291754 [TBL] [Abstract][Full Text] [Related]
2. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. The identification of heterogeneous reactive oxygen subtypes in esophageal squamous cell carcinoma to aid patient prognosis and immunotherapy. Lu Q; Yang Q; Zhao J; Li G; Zhang J; Jia C; Wan Y; Chen Y Heliyon; 2024 Aug; 10(15):e35235. PubMed ID: 39165982 [TBL] [Abstract][Full Text] [Related]
5. DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities. Zhao N; Zhang Z; Wang Q; Li L; Wei Z; Chen H; Zhou M; Liu Z; Su J EBioMedicine; 2023 Oct; 96():104801. PubMed ID: 37725855 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
7. Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma. Shi R; Zhao H; Zhao S; Yuan H Aging (Albany NY); 2022 Jun; 14(12):5271-5291. PubMed ID: 35771147 [TBL] [Abstract][Full Text] [Related]
8. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma. Zhang Y; Chen Y Front Cell Dev Biol; 2022; 10():855404. PubMed ID: 35493093 [TBL] [Abstract][Full Text] [Related]
9. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY Front Genet; 2022; 13():853113. PubMed ID: 35734437 [No Abstract] [Full Text] [Related]
10. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis. Weng NQ; Chi J; Wen J; Mai SJ; Zhang MY; Huang L; Liu J; Yang XZ; Xu GL; Fu JH; Wang HY J Transl Med; 2020 Jan; 18(1):47. PubMed ID: 32005248 [TBL] [Abstract][Full Text] [Related]
12. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma. Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093 [TBL] [Abstract][Full Text] [Related]
13. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
14. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer. Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive single-cell transcriptomic profiling reveals molecular subtypes and prognostic biomarkers with implications for targeted therapy in esophageal squamous cell carcinoma. Zhang D; Zhao F; Li J; Guo P; Liu H; Lu T; Li S; Li Z; Li Y Transl Oncol; 2024 Jun; 44():101948. PubMed ID: 38582059 [TBL] [Abstract][Full Text] [Related]
16. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile. Peng M Front Immunol; 2022; 13():970885. PubMed ID: 36003383 [TBL] [Abstract][Full Text] [Related]
17. Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets. Song D; Wei Y; Hu Y; Sun Y; Liu M; Ren Q; Hu Z; Guo Q; Wang Y; Zhou Y Clin Transl Oncol; 2022 Jun; 24(6):1100-1114. PubMed ID: 35098447 [TBL] [Abstract][Full Text] [Related]
18. Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value. Wang D; Dai J; Suo C; Wang S; Zhang Y; Chen X Front Genet; 2022; 13():1033214. PubMed ID: 36425064 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
20. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes. Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]